Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #1020

    ORR seems to be similar https://ash.confex.com/ash/2020/webprogram/Paper133820.html

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #1021

      But fewer pts in the epco abstract from ash

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #1022

        ORR was 100% at the 48 mg dose (epco)

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #1023

          So all in all, efficacy not worse, safety better, and sc convenience. My opinion.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #1024

            i am not sure if this Glofitamab data is new after ASH; it says data cutoff August 3 2020, have to look into it

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1025

              The epco data in the table from ash is a snapshot from July 6.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #1026

                yes, so one would think the Glofitamab august 3 data was probably at ASH already?

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #1027

                  Not these data. Ash-data was of April 17 https://ash.confex.com/ash/2020/webprogram/Paper136044.html

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #1028

                    So these glofi-data are newer. We'll have to wait for the expansion-data of epco with more pts and RP2D.

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #1029

                      ok. we'll probably see updates of both at ASCO?

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #1030

                        Expansion part is pretty big. 486 pts https://www.clinicaltrials.gov/ct2/show/NCT03625037?term=Epcoritamab&draw=2&rank=5

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #1031

                          Yes let's hope for asco. Primary completion is January next year. So at ash as the latest probably.

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #1032

                            man kan også bemærke at de er nødt til at give obinutuzumab forud 'to reduce toxicity'

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1033

                              yes, i think we can have good hope epco is safer and easier to administer. But it will also be a race to FDA approval, how much quicker will Roche be...

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #1034

                                Ja, det pynter jo ikke med grade 3/4 CRS

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1035

                                  SGEN virtual
                                  booth https://seattlegeneticsvirtualexperience.com/gynecology/

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #1036

                                    https://thehill.com/policy/healthcare/public-global-health/544000-biontech-founder-says-next-problem-to-tackle-with-mrna
                                    BioNTech founder says cancer is next problem to tackle with mRNA tech

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #1037

                                      Langers Skarpe: Aktiemarkeder foran højrisikoperiode
                                      https://www.proinvestor.com/investornyt/673311/langers-skarpe-aktiemarkeder-foran-hojrisikoperiode

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #1038

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #1039

                                          Hallå! Købere. Vi mangler købere. Vi har lige nu tilbud på Genmab. Den bliver ikke billigere. Det er nu De skal slå til frue, hvis De vil gøre en god handel.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger